v3.26.3
Investment in Equity Securities - Schedule of Converted Basis Using The Quoted Price of Glucotrack Common Stock (Details) - Glucotrack [Member]
3 Months Ended
Sep. 30, 2026
USD ($)
Schedule of Converted Basis Using The Quoted Price of Glucotrack Common Stock [Line Items]  
Fair value at July 14, 2026 $ 962,935
Change in fair value — three months ended September 30, 2026 (710,705)
Balance at September 30, 2026 $ 252,230